Prognostic relevance of mutations and copy number alterations assessed with targeted next generation sequencing in IDH mutant grade II glioma
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1573-7373
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Prognostic relevance of mutations and copy number alterations assessed with targeted next generation sequencing in IDH mutant grade II glioma ; day:16 ; month:4 ; year:2018 ; pages:1-9
Journal of neuro-oncology ; (16.4.2018), 1-9
- Urheber
-
Wijnenga, Maarten M. J.
- Beteiligte Personen und Organisationen
-
French, Pim J.
Dubbink, Hendrikus J.
Dinjens, Winand N. M.
Atmodimedjo, Peggy N.
Kros, Johan M.
Fleischeuer, Ruth
Dirven, Clemens M. F.
Vincent, Arnaud J. P. E.
Van den Bent, Martin J.
SpringerLink (Online service)
- DOI
-
10.1007/s11060-018-2867-8
- URN
-
urn:nbn:de:101:1-2018062023121805614525
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:22 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Wijnenga, Maarten M. J.
- French, Pim J.
- Dubbink, Hendrikus J.
- Dinjens, Winand N. M.
- Atmodimedjo, Peggy N.
- Kros, Johan M.
- Fleischeuer, Ruth
- Dirven, Clemens M. F.
- Vincent, Arnaud J. P. E.
- Van den Bent, Martin J.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Updates on the WHO diagnosis of IDH-mutant glioma
Treatment of IDH-mutant glioma in the INDIGO era
Linking epigenetic signature and metabolic phenotype in IDH mutant and IDH wildtype diffuse glioma
Linking epigenetic signature and metabolic phenotype in IDH mutant and IDH wildtype diffuse glioma
A patient-derived cell model for malignant transformation in IDH-mutant glioma
ATRX regulates glial identity and the tumor microenvironment in IDH-mutant glioma
Energy metabolism-related GLUD1 contributes to favorable clinical outcomes of IDH-mutant glioma
Therapies for IDH-Mutant Gliomas
PERK‐Mediated Cholesterol Excretion from IDH Mutant Glioma Determines Anti‐Tumoral Polarization of Microglia
Comprehensive analysis of the REST transcription factor regulatory networks in IDH mutant and IDH wild-type glioma cell lines and tumors
Mutant IDH and non-mutant chondrosarcomas display distinct cellular metabolomes
Stalled oligodendrocyte differentiation in IDH-mutant gliomas
Updates on the WHO diagnosis of IDH-mutant glioma
Treatment of IDH-mutant glioma in the INDIGO era
Linking epigenetic signature and metabolic phenotype in IDH mutant and IDH wildtype diffuse glioma
Linking epigenetic signature and metabolic phenotype in IDH mutant and IDH wildtype diffuse glioma
A patient-derived cell model for malignant transformation in IDH-mutant glioma
ATRX regulates glial identity and the tumor microenvironment in IDH-mutant glioma
Energy metabolism-related GLUD1 contributes to favorable clinical outcomes of IDH-mutant glioma
Therapies for IDH-Mutant Gliomas
PERK‐Mediated Cholesterol Excretion from IDH Mutant Glioma Determines Anti‐Tumoral Polarization of Microglia
Comprehensive analysis of the REST transcription factor regulatory networks in IDH mutant and IDH wild-type glioma cell lines and tumors
Mutant IDH and non-mutant chondrosarcomas display distinct cellular metabolomes
Stalled oligodendrocyte differentiation in IDH-mutant gliomas
Updates on the WHO diagnosis of IDH-mutant glioma
Treatment of IDH-mutant glioma in the INDIGO era
Linking epigenetic signature and metabolic phenotype in IDH mutant and IDH wildtype diffuse glioma
Linking epigenetic signature and metabolic phenotype in IDH mutant and IDH wildtype diffuse glioma
A patient-derived cell model for malignant transformation in IDH-mutant glioma
ATRX regulates glial identity and the tumor microenvironment in IDH-mutant glioma
Energy metabolism-related GLUD1 contributes to favorable clinical outcomes of IDH-mutant glioma
Therapies for IDH-Mutant Gliomas
PERK‐Mediated Cholesterol Excretion from IDH Mutant Glioma Determines Anti‐Tumoral Polarization of Microglia
Comprehensive analysis of the REST transcription factor regulatory networks in IDH mutant and IDH wild-type glioma cell lines and tumors
Mutant IDH and non-mutant chondrosarcomas display distinct cellular metabolomes